Matthew Harris
Fortune : 25 M $ au 30/06/2026
Fortune : 25 M $ au 30/06/2026
Matthew Harris is the founder and the Chief Scientific Officer of Clarity Pharmaceuticals Ltd., a company founded in 2010.
He was previously the Chief Executive Officer of Gateway Capital Ltd. and a Non-Executive Director at Genera Biosystems Ltd. from 2007 to 2008.
Dr. Harris holds a doctorate from The Australian National University and an MBA from the Australian Graduate School of Management.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/08/2025 | 16 699 842 ( 4,48 % ) | 25 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Fondateur | 01/01/2010 |
| Sociétés | Poste | Fin |
|---|---|---|
| GENERA BIOSYSTEMS LIMITED | Directeur/Membre du Conseil | 12/12/2008 |
Gateway Capital Ltd.
Gateway Capital Ltd. Financial ConglomeratesFinance Investment firm | President | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Australian National University
Australian National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gateway Capital Ltd.
Gateway Capital Ltd. Financial ConglomeratesFinance Investment firm | Finance |
Genera Biosystems Ltd.
Genera Biosystems Ltd. Medical SpecialtiesHealth Technology Manufactures, develops and commercializes multiplexed molecular diagnostic tests | Health Technology |
Australian Graduate School of Management
Australian Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops radiopharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national